FOXO4-DRI × Humatide Peptides — lab test, August 2026
COA COA-2026-BKC81I matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
SAP84NC2Test results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.27 mg
103% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.6 mg using the measured mass, against 2.5 mg on the label — 3% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-BKC81I |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Submitted via | Shop panel (bulk upload) |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of FOXO4-DRI from Humatide Peptides, performed by ILS Laboratories on August 5, 2026. Reported purity: 98.29%. Net content: 10.27 mg against 10 mg labeled (103% of label). Batch H10FOXO073126. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion